July 1, 2025 · Form 4 insider transaction
Feeley Kevin sold 998 shares of GeneDx Holdings Corp. at $90.86 per share, a transaction worth $90.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2024.; The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.366 to $91.2988 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.